DRW3 logo

Drägerwerk KGaA Stock Price

Symbol: XTRA:DRW3Market Cap: €1.2bCategory: Healthcare

DRW3 Share Price Performance

€67.70
21.95 (47.98%)
29.5% undervalued intrinsic discount
€96.00
Fair Value
€67.70
21.95 (47.98%)
29.5% undervalued intrinsic discount
€96.00
Fair Value
Price €67.70
AnalystHighTarget €96.00
AnalystConsensusTarget €76.60
AnalystLowTarget €63.00

DRW3 Community Narratives

AN
AnalystHighTarget
AnalystHighTarget·Updated
Fair Value €96.00 29.5% undervalued intrinsic discount

Aging Populations And Digital Care Will Drive Healthcare Resilience

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value €76.60 11.6% undervalued intrinsic discount

Global Medical Demand Will Unlock Future Markets

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget·Updated
Fair Value €63.00 7.5% overvalued intrinsic discount

Geopolitical Tensions And Cost Pressures Will Mar Future Performance

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

DRW3 Community Fair Values

Recent DRW3 News & Updates

No updates

Drägerwerk AG & Co. KGaA Key Details

€3.4b

Revenue

€1.9b

Cost of Revenue

€1.5b

Gross Profit

€1.4b

Other Expenses

€99.9m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 29, 2025
Earnings per share (EPS)
5.32
Gross Margin
44.86%
Net Profit Margin
2.97%
Debt/Equity Ratio
22.3%

Drägerwerk AG & Co. KGaA Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About DRW3

Founded
1889
Employees
16609
CEO
Stefan Drager
WebsiteView website
www.draeger.com

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products include patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. In addition, the company offers alcohol and drug testing; fixed gas detectors; hazmat suits; portable gas detection; head protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply. Further, it provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.

German Market Performance

  • 7 Days: 1.5%
  • 3 Months: -3.4%
  • 1 Year: 23.4%
  • Year to Date: 5.7%
Over the last 7 days, the market has risen 1.5%, driven by gains of 13% in the Communication Services sector. On the other hand, with a decline of 6.2%, the Consumer Discretionary sector is lagging behind. In the last year, the market has climbed 23%. Earnings are forecast to grow by 17% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading